Healthcare ❯ Pharmaceuticals ❯ Drug Regulation

FDA

Mifepristone SSRIs Compounding Pharmacies Compounding Pharmacy Reapproval Process GLP-1 Agonists

HHS Denies SSRI Ban Talks as Kennedy Unveils Push to Curb Prescribing

Experts say federal law makes an outright removal of long‑approved antidepressants unlikely.

Fourth Circuit Affirms West Virginia’s Restriction on Abortion Pill Mifepristone